Drug profile · INN
erenumab-aooe
AIMOVIG
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
erenumab-aooe (AIMOVIG) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN erenumab-aooe
Brand AIMOVIG
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is erenumab-aooe?
erenumab-aooe (AIMOVIG) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for erenumab-aooe?
AIMOVIG is a marketed brand name for erenumab-aooe. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of erenumab-aooe?
erenumab-aooe has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.